These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8905035)

  • 81. Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer.
    Fujita A; Ohkubo T; Hoshino H; Takabatake H; Tagaki S; Sekine K; Abe S
    Br J Cancer; 2003 Sep; 89(6):1008-12. PubMed ID: 12966417
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
    Sculier JP; Paesmans M; Lafitte JJ; Baumöhl J; Thiriaux J; van Cutsem O; Recloux P; Bureau G; Berchier MC; Zacharias C; Mommen P; Bosschaerts T; Berghmans T; van Houtte P; Ninane V; Klastersky J
    Ann Oncol; 1999 Mar; 10(3):295-303. PubMed ID: 10355573
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.
    Omuro AM; Raizer JJ; Demopoulos A; Malkin MG; Abrey LE
    J Neurooncol; 2006 Jul; 78(3):277-80. PubMed ID: 16614943
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.
    Monnet I; de CH; Soulié P; Saltiel-Voisin S; Bekradda M; Saltiel JC; Brain E; Rixe O; Yataghene Y; Misset JL; Cvitkovic E
    Ann Oncol; 2002 Jan; 13(1):103-7. PubMed ID: 11863089
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials.
    Kosmidis P; Mylonakis N; Skarlos DV; Samantas E; Beer M; Theocharis D; Zachariadis E; Gioti A; Papadakis E; Poulakis N
    Ann Oncol; 1994 Feb; 5(2):159-62. PubMed ID: 8186159
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary.
    Provencio M; Sánchez A; Artal A; Sánchez Torres JM; García Gómez R; Constenla M; de Castro J; Dómine M; Viñolas N; Sánchez A; Pérez FJ
    Clin Transl Oncol; 2013 Aug; 15(8):659-64. PubMed ID: 23359178
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combination chemotherapy for advanced bilharzial bladder carcinoma.
    Khaled HM; Gad el-Mawla N; el-Said A; Hamza MR; Gaafar R; el-Attar I; Abu Rabia A; Magrath I
    Ann Oncol; 1996 Sep; 7(7):751-4. PubMed ID: 8905036
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients.
    Barlesi F; Imbs DC; Tomasini P; Greillier L; Galloux M; Testot-Ferry A; Garcia M; Elharrar X; Pelletier A; André N; Mascaux C; Lacarelle B; Cheikh RE; Serre R; Ciccolini J; Barbolosi D
    Oncotarget; 2017 Jul; 8(29):47161-47166. PubMed ID: 28525370
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.
    Crinò L; Corgna E; Porrozzi S; Palladino MA; Darwish S; Minotti V; Mosconi AM; Tonato M
    Ann Oncol; 1997 Jul; 8(7):709-11. PubMed ID: 9296229
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Vinorelbine (Navelbine) in the treatment of non-small-cell lung cancer: studies with single-agent therapy and in combination with cisplatin.
    Gralla R; Harper P; Johnson S; Delgado FM
    Ann Oncol; 1999; 10 Suppl 5():S41-5. PubMed ID: 10582138
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A pilot study of mitomycin, ifosfamide and cisplatin as outpatient combination chemotherapy for advanced non-small cell lung cancer.
    Mariani GL; Pennucci MC; Addamo G; Venturini M; Ardizzoni A; Rosso R
    Tumori; 1991 Dec; 77(6):511-3. PubMed ID: 1666469
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC.
    Dean EJ; Ward T; Pinilla C; Houghten R; Welsh K; Makin G; Ranson M; Dive C
    Br J Cancer; 2010 Jan; 102(1):97-103. PubMed ID: 19904270
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Targeted therapies: Cetuximab plus chemotherapy in patients with advanced NSCLC.
    Rasul KI; Kerr DJ
    Nat Rev Clin Oncol; 2009 Sep; 6(9):499-500. PubMed ID: 19707238
    [No Abstract]   [Full Text] [Related]  

  • 94. Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study.
    Bennouna J; Breton JL; Tourani JM; Ottensmeier C; O'Brien M; Kosmidis P; Huat TE; Pinel MC; Colin C; Douillard JY
    Br J Cancer; 2006 May; 94(10):1383-8. PubMed ID: 16641911
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis.
    Xu K; Liu T; Zhang J; Zhou Y; Yang F; Ren T
    Int J Clin Oncol; 2020 Sep; 25(9):1624-1634. PubMed ID: 32472208
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Weekly vinorelbine in elderly patients with non-small-cell lung cancer.
    Colleoni M; Gaion F; Nelli P; Colmellere GM; Manente P
    Tumori; 1994 Dec; 80(6):448-52. PubMed ID: 7900235
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
    Einstein MH; Klobocista M; Hou JY; Lee S; Mutyala S; Mehta K; Reimers LL; Kuo DY; Huang GS; Goldberg GL
    Gynecol Oncol; 2012 Jan; 124(1):26-30. PubMed ID: 22055846
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer.
    Harada G; Neffa MFBV; Bonadio RC; Mendoza EZ; Caparica R; Lauricella LL; Takagaki TY; Roitberg FSR; Terra RM; Castro G
    J Bras Pneumol; 2021; 47(3):e20200378. PubMed ID: 33656100
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Modulation of peripheral immune responses by paclitaxel-ifosfamide-cisplatin chemotherapy in advanced non-small-cell lung cancer.
    Koufos N; Michailidou D; Xynos ID; Tomos P; Athanasiadou K; Kosmas C; Tsavaris N
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):1995-2003. PubMed ID: 24072231
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa.
    Stein ME; Ruff P; Weaving A; Fried J; Bezwoda WR
    Am J Clin Oncol; 1996 Aug; 19(4):386-8. PubMed ID: 8677911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.